Saturday, May 08, 2010

Adding more soon

Friday, April 07, 2006

IFPMA Clinical Trials Portal

New tool cutesy of IBM: Clinical trial locator: http://www.ifpma.org/clinicaltrials.html

You can easily search the database of over 80 thousand ongoing trials

The new portal uses an IBM search software called OmniFind. The OmniFind tool agrigates disparate information to make it searchable such as PDF, text, and HTML files. OmniFind sifts through different data types from many different sources (including, databases and websites), and captures the pertinant information within documents that best matchs the search.

This system will refer you primarily to the government clinical trials site but as ClinicalTrials.gov dosn't maintain files on all studies IFPMA may also refer you to other corporate or university sites for details on each study.

As good as this tool is I will continue highlighting studies as they come to my attention and post them here but I also want to make the tools available. Watch the right hand panel for new links!

Cheers

Tom



I'll be adding this link to the right tomorrow.



Tuesday, January 03, 2006

Clinical Trial of "Rimonabant" - reduction of alcohal consumption.

National Institute of Health (NIH) Clinical Trial of "Rimonabant",
in the Voluntary
reduction of alcohal consumption.

Study # 04-AA-0072

Recruitment Status: Currently recruiting new subjects
Location: NIH - Bethesda, Maryland
This is a short term study requiring an overnight stay
(Note this is a study of "Healthy", that is Non-Treatment seeking people.)
This study will examine whether Rimonabant, a drug that blocks
cannabinoid receptors in the brain, affects alcohol consumption. Substances called endocannabinoids have many of the same
effects of marijuana to bind to these receptors. Animal studies show that
when cannabinoid receptors are blocked, animals consume less alcohol.
This study is open to:

Healthy normal volunteers between 21 and 40 years of age who consume between 20 and 40 alcoholic drinks per week. For more information
If interested Contact:
Patient Recruitment and Public Liaison Office http://www.cc.nih.gov/ccc/prpl/
Bethesda, Maryland
Toll Free: 1-800-411-1222
Electronic Mail:prpl@mail.cc.nih.gov

TB
Sponsored by Drug Rehab Lifeline


Tuesday, December 27, 2005

Phase II study of Naltrexone in relapse prevention for cocaine addiction. University of Texas


http://clinicaltrials.gov/show/NCT00218023

Screening Medications for Cocaine Cessation and Relapse Prevention

A clinical trial to confirm the effectiveness of drug therapies in preventing relapse into cocaine addiction. This is part of a Phase II study of the drug Naltrexone .This is an ongoing trial at the University of Texas National Institute on Drug Abuse (NIDA) Contact information and eligibility requirements can be found on the above URL limited to 200 people study commenced in September 2005

This site is Sponsored by Drug Rehab Lifeline @ Drugrehablifeline.org

Substance Abuse Treatment for Heroin Addicted Men and Women in Puget Sound area WA

http://www.brtc.psych.washington.edu/research.html

Substance Abuse Treatment for Heroin Addicted Men and Women

University of Washington - Behavioral Research and Therapy Clinics (BRTC)

Puget Sound men and women with an opiate addiction and women with suicidal behavior are needed as volunteers for two studies at the University of Washington designed to refine a therapeutic treatment for borderline personality disorder.

http://www.uwnews.org/article.asp?articleID=12695

BRTC is Looking for People who match the characteristics below:

  • Men or women between the ages of 18 and 60
  • No mandate or court order for treatment
  • Willing to go on opium replacement medication
  • Cannot be pregnant
  • Live within commuting distance of the University of Washington Seattle campus
  • Willing to discontinue current treatment including psychotropic medication if accepted into treatment program

If you are interested in participating in a study or would like to refer a client to this study please call our Participant Coordinator at 206-543-2782 x1. or contact: Joel Schwarz joels@u.washington.edu

Sponsored By: Drug Rehab Lifeline

Introduction: Shedding Light on Addiction - Participant Studies & Clinical Trials


While researching information for our science news blog: Science: Shedding Light on Addiction , we were surprised at the number of clinical trials being conducted around the country. Trials and studies offer a possible alternative option for people looking for treatment but unable to afford the high cost of residential or even outpatient treatment. Studies often include a stipend for transportation, medications, therapy and follow-up. Also they will usually help the participant link up with other services in their area.


Our goal with this blog is to make timely information available, we are planning weekly updates on new and ongoing studies nationwide.

Science: Shedding Light on Addiction - Participant Studies & Clinical Trials
is Sponsored by: Drug Rehab Lifeline